Mastopexy Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the mastopexy market.
How Fast Is The Mastopexy Market Growing Towards 2025?
The mastopexy market size has grown strongly in recent years. It will grow from $2.36 billion in 2024 to $2.51 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing social acceptance and normalization of cosmetic procedures, increasing the number of patients undergoing bariatric surgery, adoption of virtual consultations and telemedicine, the increasing establishment of specialized cosmetic surgery, and adoption of patient-centered care models in cosmetic surgery.
The mastopexy market size is expected to see strong growth in the next few years. It will grow to $3.19 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to enhanced pre-operative counseling and post-operative care, growing focus on overall health and self-care motivates, enhanced anesthesia techniques, an aging population, and higher disposable incomes. Major trends in the forecast period include advancements in implant technology, advancements in surgical training and education, regenerative medicine advances, advancements in scar management, and ongoing research and clinical trials.
Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18405&type=smp
Mastopexy Market Drivers And Opportunities
The rising female geriatric population is expected to propel the growth of the mastopexy market going forward. The female geriatric population refers to women who are elderly or aged, typically defined as aged 65 years and older. The female geriatric population is growing due to increased life expectancy, advancements in healthcare leading to improved overall health outcomes, and declining birth rates in many countries. Mastopexy, or breast lift surgery, is increasingly used in geriatric women to improve breast contour and address age-related changes. For instance, in 2023, according to the World Bank Group, a US-based international financial institution that provides loans and grants, the percentage of females aged 65 and above in the United States increased from 18.1% in 2021 to 19.1% in 2023. Therefore, the rising female geriatric population is driving the growth of the mastopexy market.
How Is The Mastopexy Market Segmented?
The mastopexymarket covered in this report is segmented —
1) By Type: Benelli Lift Or Donut Lift; Crescent Breast Lift; Lollipop Lift; Anchor Breast Lift
2) By Tissue Incision: Skin; Adipose; Glandular
3) By End Use: Hospitals; Specialty Clinics
Subsegments:
1) By Benelli Lift Or Donut Lift: Periareolar Mastopexy; Circumareolar Mastopexy
2) By Crescent Breast Lift: Partial Crescent Lift; Full Crescent Lift
3) By Lollipop Lift: Vertical Mastopexy; Single Vertical Incision Mastopexy
4) By Anchor Breast Lift: Inverted T Mastopexy; Wise Pattern Mastopexy
What Are The Future Trends Of The Mastopexy Market?
Major companies operating in the mastopexy market are focusing on developing advanced products, such as nipple reconstruction solutions, to gain a competitive edge in the market. Nipple reconstruction solutions refer to surgical techniques and implants used to recreate the nipple-areola complex for patients who have undergone mastectomy or breast reconstruction surgery, aiming to restore natural appearance and symmetry to the breast mound. These solutions often utilize advanced materials and precise surgical techniques to achieve realistic texture, projection, and aesthetic integration with the surrounding breast tissue. For instance, in March 2024, GC Aesthetics, an Ireland-based medical technology company, introduced the FixNip NRI, a nipple implant aimed at transforming breast reconstruction for women. This implant is designed to elevate the standard of care in total breast reconstruction by offering a durable and natural-looking nipple-areola complex (NAC) reconstruction. Constructed from biocompatible, smooth silicone, the FixNip NRI features a floral-shaped nitinol frame. This innovative design facilitates minimal incisions and ensures the implant recovers its original shape when folded and inserted.
Major Companies Operating In The Mastopexy Market Are:
Major companies operating in the mastopexy market are AbbVie Inc., Hologic Inc., Spire Healthcare Group plc, Cynosure Inc., Silimed — Industria Ltda Implants, Establishment Labs Holdings Inc., Aurora Clinics, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics, Sebbin SAS, Laboratoires Arion, Polytech Health & Aesthetics GmbH, Ideal Implant Incorporated, Surgiform Technology Ltd, The Esthetic Clinics, Olympus Cosmetic Group, Q Medical Industries, Guangzhou Wanhe Plastic Materials, Rau Plastic Surgery
View the full mastopexy market report here:
https://www.thebusinessresearchcompany.com/report/mastopexy-global-market-report
Regional Analysis: Opportunities And Challenges In The Mastopexy Market
North America was the largest region in the mastopexy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mastopexy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment